NCT01159158View on ClinicalTrials.gov

Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Healthy
Interventions
DRUG

Nateglinide

Nateglinide Tablets 120 mg

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY